Skip to content

Calix CALX Options canceled (in dollars per share)

Options canceled (in dollars per share) at other companies

Ondas, Inc.
 logo
Ondas, Inc. ONDS
$5.42+274%
Xylem logo
XylemXYL
$127.87+13.3%
Oruka Therapeutics, Inc. logo
Oruka Therapeutics, Inc.ORKA
$15.04
Avanos Medical logo
Avanos MedicalAVNS
$31.83-14.8%
Playtika Holding Corp. logo
Playtika Holding Corp.PLTK
$16.65-12.0%
Bicara Therapeutics logo
Bicara TherapeuticsBCAX
$0.00

Other financials

Income statement

See full
Revenue$280.0M+27.1%
Gross profit$159.3M+29.8%
Operating income$12.7M+309%
Net income$11.2M+334%
EPS (diluted)$0.16+329%

Balance sheet

See full
Cash & equivalents$54.6M+29.1%
Total debt$14.7M+109%
Total equity$738.0M-3.8%
Total assets$951.4M+3.7%

Cash flow

See full
Operating cash flow$14.6M-15.0%
CapEx$8.1M+88.4%
Free cash flow$6.5M-49.5%

Valuation

See full
Market cap$2.33B+34.0%
Enterprise value$2.29B+34.3%
P/E68.8×
P/S2.2×+0.1×

Profitability

See full
Gross margin57.1%+2.1pp
Operating margin3.8%+2.3pp
Net margin3.2%+2.0pp
FCF margin10.3%+4.0pp

Returns & leverage

See full
Return on equity4.5%+3.0pp
Debt / equity0.0×
Current ratio3.3×-1.3×

Where this comes from

Reported directly by Calix in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice.

The official record: Calix’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Calix's options canceled (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Calix's options canceled (in dollars per share)?
Calix (CALX) reported options canceled (in dollars per share) of $35.00 in Q4 2025.
How has Calix's options canceled (in dollars per share) changed year-over-year?
Calix's options canceled (in dollars per share) decreased by 32.5% year-over-year, from $51.88 to $35.00.
What does options canceled (in dollars per share) mean?
The average exercise price or valuation associated with stock options that were canceled during the reporting period. This reflects the impact of expired or forfeited equity awards on the company's total compensation structure.